Which pharmacologic class is commonly used as a first-line treatment for urge incontinence and works by blocking muscarinic receptors?

• A. Antimuscarinics
• B. Beta-adrenergic agonists
• C. Alpha blockers
• D. Vasodilators

Answer: (A)

Urge incontinence arises from overactivity of the detrusor muscle, driven by acetylcholine acting on muscarinic receptors. Blocking those receptors reduces involuntary detrusor contractions, increases bladder capacity, and thus decreases urgency and leakage. This is exactly what antimuscarinic drugs do, making them the typical first-line pharmacologic therapy forurge incontinence. Examples include agents that block muscarinic receptors in the bladder to calm overactivity. Other options exist—beta-adrenergic agonists like mirabegron relax the detrusor through a different mechanism and can be used when antimuscarinics aren’t suitable; alpha blockers and vasodilators address other conditions and don’t target detrusor overactivity in the same way. The core idea is that blocking muscarinic receptors in the bladder reduces urge symptoms, which is the action of antimuscarinic medications.